Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Estimating the burden of iron deficiency among African children.

Muriuki JM, Mentzer AJ, Webb EL, Morovat A, Kimita W, Ndungu FM, Macharia AW, Crane RJ, Berkley JA, Lule SA, Cutland C, Sirima SB, Diarra A, Tiono AB, Bejon P, Madhi SA, Hill AVS, Prentice AM, Suchdev PS, Elliott AM, Williams TN, Atkinson SH.

BMC Med. 2020 Feb 27;18(1):31. doi: 10.1186/s12916-020-1502-7.

2.

How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study.

Challenger JD, Gonçalves BP, Bradley J, Bruxvoort K, Tiono AB, Drakeley C, Bousema T, Ghani AC, Okell LC.

BMJ Glob Health. 2019 Dec 10;4(6):e001856. doi: 10.1136/bmjgh-2019-001856. eCollection 2019.

3.

P. falciparum gametocyte density and infectivity in peripheral blood and skin tissue of naturally infected parasite carriers in Burkina Faso.

Meibalan E, Barry A, Gibbins MP, Awandu S, Meerstein-Kessel L, Achcar F, Bopp S, Moxon C, Diarra A, Debe S, Ouédraogo N, Barry-Some I, Badoum E, Fagnima T, Lanke K, Gonçalves BP, Bradley J, Wirth D, Drakeley C, Guelbeogo WM, Tiono AB, Marti M, Bousema T.

J Infect Dis. 2019 Dec 26. pii: jiz680. doi: 10.1093/infdis/jiz680. [Epub ahead of print]

PMID:
31875909
4.

Assessing the impact of the addition of pyriproxyfen on the durability of permethrin-treated bed nets in Burkina Faso: a compound-randomized controlled trial.

Toé KH, Mechan F, Tangena JA, Morris M, Solino J, Tchicaya EFS, Traoré A, Ismail H, Maas J, Lissenden N, Pinder M, Lindsay SW, Tiono AB, Ranson H, Sagnon N.

Malar J. 2019 Dec 2;18(1):383. doi: 10.1186/s12936-019-3018-1.

5.

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum.

Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gonçalves BP, Stone W, Chen I, Lanke K, Neuvonen M, Mustaniemi AL, Eziefula AC, Gosling R, D'Alessandro U, Drakeley C, Niemi M, Bousema T.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00538-19. doi: 10.1128/AAC.00538-19. Print 2019 Oct.

6.

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso.

Barry A, Behet MC, Nébié I, Lanke K, Grignard L, Ouedraogo A, Soulama I, Drakeley C, Sauerwein R, Bolscher JM, Dechering KJ, Bousema T, Tiono AB, Gonçalves BP.

Version 2. Wellcome Open Res. 2019 May 1 [revised 2019 Jan 1];3:159. doi: 10.12688/wellcomeopenres.14932.2. eCollection 2018.

7.

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria.

Grignard L, Mair C, Curry J, Mahey L, Bastiaens GJH, Tiono AB, Okebe J, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Lanke KHW, Sirima SB, d'Alessandro U, Clark TG, Campino S, Bousema T, Drakeley C.

Malar J. 2019 Jan 21;18(1):14. doi: 10.1186/s12936-019-2648-7.

8.

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Tiono AB, Nébié I, Anagnostou N, Coulibaly AS, Bowyer G, Lam E, Bougouma EC, Ouedraogo A, Yaro JBB, Barry A, Roberts R, Rampling T, Bliss C, Hodgson S, Lawrie A, Ouedraogo A, Imoukhuede EB, Ewer KJ, Viebig NK, Diarra A, Leroy O, Bejon P, Hill AVS, Sirima SB.

PLoS One. 2018 Dec 12;13(12):e0208328. doi: 10.1371/journal.pone.0208328. eCollection 2018.

9.

Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial.

Tiono AB, Ouédraogo A, Ouattara D, Bougouma EC, Coulibaly S, Diarra A, Faragher B, Guelbeogo MW, Grisales N, Ouédraogo IN, Ouédraogo ZA, Pinder M, Sanon S, Smith T, Vanobberghen F, Sagnon N, Ranson H, Lindsay SW.

Lancet. 2018 Aug 18;392(10147):569-580. doi: 10.1016/S0140-6736(18)31711-2. Epub 2018 Aug 10. Erratum in: Lancet. 2018 Aug 25;392(10148):636.

PMID:
30104047
10.

Haemolysis and haem oxygenase-1 induction during persistent "asymptomatic" malaria infection in Burkinabé children.

Mooney JP, Barry A, Gonçalves BP, Tiono AB, Awandu SS, Grignard L, Drakeley CJ, Bottomley C, Bousema T, Riley EM.

Malar J. 2018 Jul 6;17(1):253. doi: 10.1186/s12936-018-2402-6.

11.

Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding.

Grignard L, Gonçalves BP, Early AM, Daniels RF, Tiono AB, Guelbéogo WM, Ouédraogo A, van Veen EM, Lanke K, Diarra A, Nebie I, Sirima SB, Targett GA, Volkman SK, Neafsey DE, Wirth DF, Bousema T, Drakeley C.

Int J Parasitol. 2018 Jul;48(8):671-677. doi: 10.1016/j.ijpara.2018.02.005. Epub 2018 May 5.

12.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

Bastiaens GJH, Tiono AB, Okebe J, Pett HE, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Bradley J, Lanke KHW, Niemi M, Sirima SB, d'Alessandro U, Bousema T, Drakeley C.

PLoS One. 2018 Jan 11;13(1):e0190272. doi: 10.1371/journal.pone.0190272. eCollection 2018.

13.

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.

Gonçalves BP, Kapulu MC, Sawa P, Guelbéogo WM, Tiono AB, Grignard L, Stone W, Hellewell J, Lanke K, Bastiaens GJH, Bradley J, Nébié I, Ngoi JM, Oriango R, Mkabili D, Nyaurah M, Midega J, Wirth DF, Marsh K, Churcher TS, Bejon P, Sirima SB, Drakeley C, Bousema T.

Nat Commun. 2017 Oct 26;8(1):1133. doi: 10.1038/s41467-017-01270-4.

14.

A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.

Macintyre F, Adoke Y, Tiono AB, Duong TT, Mombo-Ngoma G, Bouyou-Akotet M, Tinto H, Bassat Q, Issifou S, Adamy M, Demarest H, Duparc S, Leroy D, Laurijssens BE, Biguenet S, Kibuuka A, Tshefu AK, Smith M, Foster C, Leipoldt I, Kremsner PG, Phuc BQ, Ouedraogo A, Ramharter M; OZ-Piperaquine Study Group.

BMC Med. 2017 Oct 9;15(1):181. doi: 10.1186/s12916-017-0940-3.

15.

Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.

Tadesse FG, Lanke K, Nebie I, Schildkraut JA, Gonçalves BP, Tiono AB, Sauerwein R, Drakeley C, Bousema T, Rijpma SR.

Am J Trop Med Hyg. 2017 Jul;97(1):188-198. doi: 10.4269/ajtmh.16-0893.

16.

Pregnant Women: An Overlooked Asset to Plasmodium falciparum Malaria Elimination Campaigns?

Gonçalves BP, Walker PG, Cairns M, Tiono AB, Bousema T, Drakeley C.

Trends Parasitol. 2017 Jul;33(7):510-518. doi: 10.1016/j.pt.2017.03.001. Epub 2017 Mar 27. Review.

PMID:
28359609
17.

Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.

Gonçalves BP, Pett H, Tiono AB, Murry D, Sirima SB, Niemi M, Bousema T, Drakeley C, Ter Heine R.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02590-16. doi: 10.1128/AAC.02590-16. Print 2017 May.

18.

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.

Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, Edwards NJ, Tarama C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Afolabi MO, Tiono AB, Yaro JB, Adetifa UJ, Hodgson SH, Anagnostou NA, Roberts R, Duncan CJ, Cortese R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampmann B, Imoukhuede EB, Sirima SB, Bojang K, Hill AV, Nébié I, Ewer KJ.

Mol Ther. 2017 Feb 1;25(2):547-559. doi: 10.1016/j.ymthe.2016.11.003.

19.

Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.

Castellani J, Nsungwa-Sabiiti J, Mihaylova B, Ajayi IO, Siribié M, Afonne C, Balyeku A, Sermé L, Sanou AK, Sombié BS, Tiono AB, Sirima SB, Kabarungi V, Falade CO, Kyaligonza J, Evers SM, Paulus AT, Petzold M, Singlovic J, Gomes M.

Clin Infect Dis. 2016 Dec 15;63(suppl 5):S256-S263.

20.

Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study.

Ajayi IO, Nsungwa-Sabiiti J, Siribié M, Falade CO, Sermé L, Balyeku A, Afonne C, Sanou AK, Kabarungi V, Oshiname FO, Gansane Z, Kyaligonza J, Jegede AS, Tiono AB, Sirima SB, Diarra A, Yusuf OB, Fouque F, Castellani J, Petzold M, Singlovic J, Gomes M.

Clin Infect Dis. 2016 Dec 15;63(suppl 5):S245-S255.

21.

Using health and demographic surveillance systems for teratovigilance in Africa.

Kirakoya-Samadoulougou F, Sombié I, Ogutu B, Tinto H, Kouanda S, Tiono AB, Otieno W, Dodoo A, Kamanda M, Sankoh O.

Lancet Glob Health. 2016 Dec;4(12):e906. doi: 10.1016/S2214-109X(16)30252-2. No abstract available.

22.

Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity.

Pett H, Gonçalves BP, Dicko A, Nébié I, Tiono AB, Lanke K, Bradley J, Chen I, Diawara H, Mahamar A, Soumare HM, Traore SF, Baber I, Sirima SB, Sauerwein R, Brown J, Gosling R, Felger I, Drakeley C, Bousema T.

Malar J. 2016 Nov 8;15(1):539.

23.

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.

Sirima SB, Mordmüller B, Milligan P, Ngoa UA, Kironde F, Atuguba F, Tiono AB, Issifou S, Kaddumukasa M, Bangre O, Flach C, Christiansen M, Bang P, Chilengi R, Jepsen S, Kremsner PG, Theisen M; GMZ2 Trial Study Group.

Vaccine. 2016 Aug 31;34(38):4536-4542. doi: 10.1016/j.vaccine.2016.07.041. Epub 2016 Jul 28.

24.

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.

Afolabi MO, Tiono AB, Adetifa UJ, Yaro JB, Drammeh A, Nébié I, Bliss C, Hodgson SH, Anagnostou NA, Sanou GS, Jagne YJ, Ouedraogo O, Tamara C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Duncan CJ, Cortese R, Nicosia A, Roberts R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampman B, Bejon P, Imoukhuede EB, Ewer KJ, Hill AV, Bojang K, Sirima SB.

Mol Ther. 2016 Aug;24(8):1470-7. doi: 10.1038/mt.2016.83. Epub 2016 Apr 25.

25.

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.

Gonçalves BP, Tiono AB, Ouédraogo A, Guelbéogo WM, Bradley J, Nebie I, Siaka D, Lanke K, Eziefula AC, Diarra A, Pett H, Bougouma EC, Sirima SB, Drakeley C, Bousema T.

BMC Med. 2016 Mar 8;14:40. doi: 10.1186/s12916-016-0581-y.

26.

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso.

Soulama I, Sermé SS, Bougouma EC, Diarra A, Tiono AB, Ouedraogo A, Konate AT, Nebie I, Sirima SB.

J Parasitol Res. 2015;2015:985651. doi: 10.1155/2015/985651. Epub 2015 Nov 8.

27.
28.

[Effect of a large scale community-based distribution of artemether-lumefantrine on its therapeutic efficacy among children living in a rural area of Burkina Faso].

Siribié M, Diarra A, Tiono AB, Soulama I, Sirima SB.

Bull Soc Pathol Exot. 2015 Mar;108(2):120-3. doi: 10.1007/s13149-015-0420-y. Epub 2015 Feb 27. French.

PMID:
25925810
29.

Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).

Tiono AB, Tinto H, Alao MJ, Meremikwu M, Tshefu A, Ogutu B, Ouedraogo A, Lingani M, Cousin M, Lefèvre G, Jain JP, Duparc S, Hamed K.

Malar J. 2015 Apr 15;14:157. doi: 10.1186/s12936-015-0682-7.

30.

Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study.

Chandra R, Ansah P, Sagara I, Sie A, Tiono AB, Djimde AA, Zhao Q, Robbins J, Penali LK, Ogutu B.

Malar J. 2015 Mar 10;14:108. doi: 10.1186/s12936-015-0620-8.

32.

Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia.

Mangano VD, Kabore Y, Bougouma EC, Verra F, Sepulveda N, Bisseye C, Santolamazza F, Avellino P, Tiono AB, Diarra A, Nebie I, Rockett KA, Sirima SB, Modiano D; MalariaGEN Consortium.

J Infect Dis. 2015 Aug 15;212(4):626-34. doi: 10.1093/infdis/jiv098. Epub 2015 Feb 23.

33.

Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.

Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW.

Malar J. 2014 Nov 25;13:458. doi: 10.1186/1475-2875-13-458.

34.

Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.

Ouédraogo AL, Bastiaens GJ, Tiono AB, Guelbéogo WM, Kobylinski KC, Ouédraogo A, Barry A, Bougouma EC, Nebie I, Ouattara MS, Lanke KH, Fleckenstein L, Sauerwein RW, Slater HC, Churcher TS, Sirima SB, Drakeley C, Bousema T.

Clin Infect Dis. 2015 Feb 1;60(3):357-65. doi: 10.1093/cid/ciu797. Epub 2014 Nov 19. Erratum in: Clin Infect Dis. 2016 Sep 1;63(5):715.

PMID:
25414262
35.

Erratum to: Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial.

Tiono AB, Diarra A, Sanon S, Nébié I, Konaté AT, Pagnoni F, Sirima SB.

Infect Dis Ther. 2013 Dec;2(2):227. doi: 10.1007/s40121-013-0017-3. No abstract available.

36.

Novel genotyping tools for investigating transmission dynamics of Plasmodium falciparum.

Wampfler R, Timinao L, Beck HP, Soulama I, Tiono AB, Siba P, Mueller I, Felger I.

J Infect Dis. 2014 Oct 15;210(8):1188-97. doi: 10.1093/infdis/jiu236. Epub 2014 Apr 25.

37.

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.

Nébié I, Edwards NJ, Tiono AB, Ewer KJ, Sanou GS, Soulama I, Sanon S, Diarra A, Yaro JB, Kangoye D, Imoukhuede EB, Hill AV, Sirima SB.

Clin Vaccine Immunol. 2014 Jun;21(6):901-3. doi: 10.1128/CVI.00723-13. Epub 2014 Apr 16. Erratum in: Clin Vaccine Immunol. 2014 Sep;21(9):1376.

38.

Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods.

Tiono AB, Kangoye DT, Rehman AM, Kargougou DG, Kaboré Y, Diarra A, Ouedraogo E, Nébié I, Ouédraogo A, Okech B, Milligan P, Sirima SB.

PLoS One. 2014 Jan 24;9(1):e86936. doi: 10.1371/journal.pone.0086936. eCollection 2014.

39.

Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso.

Tiono AB, Ouédraogo A, Diarra A, Coulibaly S, Soulama I, Konaté AT, Barry A, Mukhopadhyay A, Sirima SB, Hamed K.

Malar J. 2014 Jan 27;13:30. doi: 10.1186/1475-2875-13-30.

40.

Laboratory evaluation of Fendona 6SC treated bednets and Interceptor long-lasting nets against Anopheles gambiae s.l. in Burkina Faso.

Badolo A, Guelbéogo WM, Tiono AB, Traoré A, Sagnon N, Sirima SB.

Parasitol Res. 2014 Mar;113(3):1069-75. doi: 10.1007/s00436-013-3742-3. Epub 2014 Jan 15.

PMID:
24425451
41.

A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.

Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB.

PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013.

43.

Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether-Lumefantrine: Impact on the Prevalence of Anemia.

Tiono AB, Ouédraogo A, Remy C, Hamed K.

Infect Dis Ther. 2013 Jun;2(1):47-58. doi: 10.1007/s40121-013-0005-7. Epub 2013 Mar 30.

44.

Low specificity of a malaria rapid diagnostic test during an integrated community case management trial.

Tiono AB, Diarra A, Sanon S, Nébié I, Konaté AT, Pagnoni F, Sirima SB.

Infect Dis Ther. 2013 Jun;2(1):27-36. doi: 10.1007/s40121-013-0006-6. Epub 2013 May 29.

46.

A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso.

Tiono AB, Ouédraogo A, Ogutu B, Diarra A, Coulibaly S, Gansané A, Sirima SB, O'Neil G, Mukhopadhyay A, Hamed K.

Malar J. 2013 Feb 27;12:79. doi: 10.1186/1475-2875-12-79.

47.

Experimental hut evaluation of Fendona 6SC®-treated bednets and Interceptor® long-lasting nets against Anopheles gambiae s.l. in Burkina Faso.

Badolo A, Guelbeogo WM, Tiono AB, Traoré A, Sagnon N, Sirima SB.

J Vector Borne Dis. 2012 Dec;49(4):234-41.

48.

Plasmodium species occurrence, temporal distribution and interaction in a child-aged population in rural Burkina Faso.

Gnémé A, Guelbéogo WM, Riehle MM, Tiono AB, Diarra A, Kabré GB, Sagnon N, Vernick KD.

Malar J. 2013 Feb 19;12:67. doi: 10.1186/1475-2875-12-67.

49.

Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.

Ouédraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, Ouedraogo E, Bougouma EC, Soulama I, Gansané A, Ouedraogo A, Konate AT, Nebie I, Watson NL, Sanza M, Dube TJ, Sirima SB.

PLoS One. 2013;8(1):e50036. doi: 10.1371/journal.pone.0050036. Epub 2013 Jan 8.

50.

Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi-country cluster randomized trial.

Mukanga D, Tiono AB, Anyorigiya T, Källander K, Konaté AT, Oduro AR, Tibenderana JK, Amenga-Etego L, Sirima SB, Cousens S, Barnish G, Pagnoni F.

Am J Trop Med Hyg. 2012 Nov;87(5 Suppl):21-29. doi: 10.4269/ajtmh.2012.11-0816.

Supplemental Content

Loading ...
Support Center